Pharmacokinetics and toxicity of irinotecan hydrochloride: effects of polymorphisms in transporter genes

ABSTRACT: Primary outcome(s): We analyze genetic polymorphism of OATP1B1, ABCG2 and OATP2B1 and Pharmacokinetics/Pharmacodynamics of the irinotecan and metabolite and toxicity expression relations of the irinotecan hydrochloride.

DISEASE(S): Malignant Solid Tumor (pancreatic Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer,breast Cancer, Neuroendocrine Carcinoma)

PROVIDER: 2639036 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR